A poor deal for ankylosing spondylitics
Bird, H.A.
European Journal of Rheumatology and Inflammation 7(3): 69-70
1984
ISSN/ISBN: 0140-1610 PMID: 6571263 Document Number: 236731
Document emailed within 1 workday
Related Documents
Christiansen, F.T.; Hawkins, B.R.; Dawkins, R.L. 1978: Immune function in ankylosing spondylitics and their relatives: influence of disease and HLA B27 Clinical and Experimental Immunology 33(2): 270-275Barzey, S. 2005: How to deal with poor performers Nursing Times 101(36): 40-41
Collins, R.E. 1995: Surgeons and the new deal--good deal or raw deal? Annals of the Royal College of Surgeons of England 77(6 Suppl): 297-298
Davis-Jacobsen, D.; Plemons, C. 2008: Real-time claim adjudication: deal or no deal? Journal of Medical Practice Management: Mpm 23(4): 222-224
Geiger, H.J. 1967: Of the poor, by the poor, or for the poor: the mental health implications of social control of poverty programs Psychiatric Research Reports 21: 55-65
Usman Iqbal, S.; Prashker, M. 2004: Health services research in rheumatology: a great deal accomplished, a great deal left to do Rheumatic Diseases Clinics of North America 30(4): 879-898 Viii
Grazio, S.; Grubisić, F.; Nemcić, T.; Matijević, V.; Skala, H. 2009: The reliability and validity of a Croatian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with ankylosing spondylitis Reumatizam 56(2): 63-76
Sieper, J.; Braun, J. 2002: New treatment strategies in ankylosing spondylitis: Proceedings of the Ankylosing Spondylitis Workshop, Berlin, Germany, 18-19 January 2002 Annals of the Rheumatic Diseases 61 Suppl. 3: Iii1-Iii2
Villa Alcázar, L.F.; de Buergo, M.; Rico Lenza, H.; Montull Fruitós, E. 1996: Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis Journal of Rheumatology 23(7): 1194-1199
Kim, T.-J.; Shin, J.-H.; Sung, I.-H.; Lee, S.; Song, Y.; Kim, T.-H. 2016: Comparison on radiographic progression for 5 years between juvenile onset ankylosing spondylitis and adult onset ankylosing spondylitis: an observational study of the Korean SpondyloArthropathy Registry (OSKAR) data Clinical and Experimental Rheumatology 34(4): 668-672
Cotter, D.A. 2002: Poor people in poor places: local opportunity structures and household poverty Rural Sociology 67(4): 534-555
Majumder, N.; Ram, F. 2015: Explaining the role of proximate determinants on fertility decline among poor and non-poor in Asian countries PLOS one 10(2): E0115441
Mola, G.D.L.; Kombuk, B.; Amoa, A.B. 2011: Poor weight gain in late third trimester: a predictor of poor perinatal outcome for term deliveries? Papua and new Guinea Medical Journal 54(3-4): 164-173
Calin, A.; Garrett, S.; Whitelock, H.; Kennedy, L.G.; O'Hea, J.; Mallorie, P.; Jenkinson, T. 1994: A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index Journal of Rheumatology 21(12): 2281-2285
Janes, C.R.; Chuluundorj, O.; Hilliard, C.E.; Rak, K.; Janchiv, K. 2006: Poor medicine for poor people? Assessing the impact of neoliberal reform on health care equity in a post-socialist context Global Public Health 1(1): 5-30
Raphael, D; Daiski, I; Pilkington, B; Bryant, T; Dinca-Panaitescu, M; Dinca-Panaitescu, S 2012: A toxic combination of poor social policies and programmes, unfair economic arrangements and bad politics: the experiences of poor Canadians with Type 2 diabetes Critical Public Health 22(2): 127-145
Pappas, G.; Agha, A.; Rafique, G.; Khan, K.S.; Badruddin, S.H.; Peermohamed, H. 2008: Community-based approaches to combating malnutrition and poor education among girls in resource-poor settings: report of a large scale intervention in Pakistan Rural and Remote Health 8(3): 820
Mills, E. 1997: Does poor nutrition lead to poor immunity? Professional Care of Mother and Child 7(6): 165-166
Young, C.L.; Kotranski, L. 1989: Pediatric care for state's poor and near-poor Pennsylvania Medicine 92(5): 32-36
Heldmann, F.; Brandt, J.; van der Horst-Bruinsma, I.E.; Landewe, R.; Sieper, J.; Burmester, G.R.; van den Bosch, F.; de Vlam, K.; Geusens, P.; Gaston, H.; Schewe, S.; Appelboom, T.; Emery, P.; Dougados, M.; Leirisalo-Repo, M.; Breban, M.; Listing, J.; Braun, J. 2011: The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab Clinical and Experimental Rheumatology 29(4): 672-680